Lyell Immunopharma to Present at Needham Healthcare Conference
Event summary
- Lyell Immunopharma will present at the 25th Annual Needham Virtual Healthcare Conference on April 14, 2026, at 11:00 am ET.
- The presentation will be webcast live and available for replay on Lyell’s website.
- Lyell’s LyFE Manufacturing Center™ has commercial launch capability and can manufacture over 1,200 CAR T-cell doses at full capacity.
The big picture
Lyell Immunopharma’s participation in the Needham Healthcare Conference underscores its push to highlight its late-stage CAR T-cell therapies, a critical area in oncology. The company’s focus on enhancing CAR T-cell durability and function positions it within the broader trend of advancing cell therapies for both hematologic malignancies and solid tumors. With its manufacturing capabilities already in place, Lyell is poised to compete in a market increasingly dominated by scalable, next-generation therapies.
What we're watching
- Clinical Progress
- How Lyell’s next-generation CAR T-cell therapies will perform in late-stage clinical trials.
- Manufacturing Scale
- Whether Lyell’s LyFE Manufacturing Center™ can sustain production at full capacity.
- Market Positioning
- The pace at which Lyell can differentiate itself in the competitive CAR T-cell therapy landscape.
Related topics